Phase 3 Coronary Artery Disease Clinical Trials
14 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–14 of 14 trials
Recruiting
Phase 3
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
Coronary Artery DiseaseAcute Myocardial Infarction (AMI)Coronary Atherosclerosis of Native Coronary Artery
ECRI bv332 enrolled1 locationNCT07276282
Recruiting
Phase 3
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
Coronary Artery Disease
MedTrace Pharma A/S215 enrolled14 locationsNCT05134012
Recruiting
Phase 3
Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)
Chronic Coronary SyndromeStable Coronary Artery Disease CAD
Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.1,703 enrolled18 locationsNCT07195149
Not Yet Recruiting
Phase 3Phase 4
COMparative Pharmacotherapy And peRsonalised stratEgy in the management of Coronary Microvascular Dysfunction double blind randomised controlled Trial - Part 1
Angina with non obstructive coronary artery disease
Sydney Local Health District130 enrolled2 locationsACTRN12625001179426
Not Yet Recruiting
Phase 3Phase 4
COMparative Pharmacotherapy And peRsonalised stratEgy in the management of Coronary Microvascular Dysfunction double blind randomised controlled Trial - Part II
Angina with non obstructive coronary artery disease
Sydney Local Health District130 enrolled2 locationsACTRN12625001174471
Not Yet Recruiting
Phase 3
PDE-5 inhibition in Ischaemia with Non-Obstructive Coronary Arteries: a double-blinded, randomised, placebo-controlled trial (PERTINENT)
IschaemiaNon obstructive coronary artery disease
Sydney Local Health District30 enrolled1 locationACTRN12625001161415
Recruiting
Phase 3
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
Coronary Artery Disease
Weill Medical College of Cornell University600 enrolled18 locationsNCT06399692
Recruiting
Phase 3
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
Coronary Artery Disease
Weill Medical College of Cornell University600 enrolled18 locationsNCT06399705
Recruiting
Phase 3
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
Coronary Artery DiseaseLipidemiaPlaque, Atherosclerotic
NewAmsterdam Pharma300 enrolled1 locationNCT06305559
Recruiting
Phase 3
Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
Coronary Artery Disease
iVascular S.L.U.2,312 enrolled39 locationsNCT05952206
Recruiting
Phase 2Phase 3
Canagliflozin Targeting Vascular Inflammation
Coronary Artery DiseaseDiabetes Type 2
Ottawa Heart Institute Research Corporation24 enrolled1 locationNCT05427084
Recruiting
Phase 3
Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
Coronary Artery Disease
AZ Sint-Jan AV2,770 enrolled19 locationsNCT06095765
Recruiting
Phase 3
SAPT Versus DAPT in Incomplete Revascularization After CABG
Coronary Artery Disease
Campus Bio-Medico University800 enrolled1 locationNCT03789916
Recruiting
Phase 2Phase 3
LoDoCo - VRIC Low Dose Colchicine in stable coronary artery disease, Vascular Reactivity and the Inflammatory Cascade.
Coronary Artery Disease
Pfizer Cardiovascular Lipid Research Grant40 enrolled1 locationACTRN12610000397011